Save time and get answers to complex questions with AI chat
Pramlintide acetate price?When is the expected fda decision date for apotex's ruxolitinib resubmission?What are the most memorable drug brands in oral factor b inhibitors? in united statesDoes lipitor's effectiveness decrease with high fat meals?When will generic fiasap insulin be available?
See the DrugPatentWatch profile for enhertu
Short answer: No. There are no approved biosimilars of Enhertu (trastuzumab deruxtecan) as of now. What this means: - Enhertu is an antibody–drug conjugate (ADC) consisting of trastuzumab linked to deruxtecan. Developing a biosimilar for an ADC is more complex than for a plain monoclonal antibody, and no such product has been approved yet. - There are approved biosimilars to trastuzumab itself (the antibody part) from various manufacturers in different regions. These are not Enhertu biosimilars; they are biosimilars of Herceptin (trastuzumab) used for HER2-positive cancers. If you’d like, I can look up the very latest status for a specific country or region and list any ongoing development programs or announced trials related to trastuzumab deruxtecan biosimilars.
Other Questions About Enhertu :